Clinical Trials Logo

Clinical Trial Summary

This study investigates the effect of Lactobacillus reuteri probiotic strains (ATCC PTA 5289 and DSM 17938) on symptoms of viral upper-respiratory tract infections in children.


Clinical Trial Description

Lactobacillus reuteri probiotic strains (ATCC PTA 5289 and DSM 17938) have been shown to significantly reduce the number of febrile days and pain severity in upper respiratory tract infections in children aged six months to 5 years. The investigator's planned study complements this earlier publication by significantly increasing the number of cases and expanding the age range studied including children from 4 to 17 years of age diagnosed with viral upper respiratory-tract infection. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06205966
Study type Interventional
Source Szent Miklós Szolgálat Kft.
Contact Gergely Milosevits, MD, PhD
Phone +36308425722
Email drgergelymilosevits@gmail.com
Status Recruiting
Phase N/A
Start date December 21, 2023
Completion date November 30, 2025